Palmoplantar pustulosis - Ipalmoplantar Pustulosishttps://en.wikipedia.org/wiki/Pustulosis_palmaris_et_plantaris
Ipalmoplantar Pustulosis (Palmoplantar pustulosis) yinto engapheliyo ye-pustular dermatosis (oko kukuthi, i-pustulosis okanye i-pustular psoriasis) efumaneka kwiintendelezo kunye ne-soles kuphela, ebonakaliswe nge-histologically nge-intraepidermal pustules egcwele i-neutrophils. Ukusetyenziswa kwe-systemic retinoids yodwa kwaye kudityaniswa ne-photochemotherapy ukuphucula iimpawu ze- ipalmoplantar pustulosis (palmoplantar pustulosis) .

○ Unyango
I-acitretin yomlomo iyasebenza kolu hlobo lwe-psoriasis.
#Acitretin
☆ Kwiziphumo zika-2022 ze-Stiftung Warentest ezivela eJamani, ukwaneliseka kwabathengi ngeModelDerm bekungaphantsi kancinci kunokubonisana nge-telemedicine ehlawulweyo.
  • Kulo mzekelo, pompholyx inokukrokrelwa kwakhona.
  • Ukungabikho kwe-pustules, i-eczema yesandla nayo ingaqwalaselwa njengoxilongo oluhlukeneyo.
References Palmoplantar Psoriasis 28846363 
NIH
Palmoplantar psoriasis luhlobo lwe-psoriasis oluchaphazela kakhulu ulusu ezintendeni zezandla zakho kunye neenyawo. Ibonakala njengolusu olujiyileyo nokuba ngomile, ukudumba, okanye indibaniselwano yazo zombini ezi ndidi.
Palmoplantar psoriasis is a variant of psoriasis that characteristically affects the skin of the palms and soles. It features hyperkeratotic, pustular, or mixed morphologies.
 Tumor Necrosis Factor Inhibitors 29494032 
NIH
Tumor necrosis factor (TNF)-alpha inhibitors, including etanercept (E), infliximab (I), adalimumab (A), certolizumab pegol (C), and golimumab (G), are biologic agents which are FDA-approved to treat ankylosing spondylitis (E, I, A, C, and G), Crohn disease (I, A and C), hidradenitis suppurativa (A), juvenile idiopathic arthritis (A), plaque psoriasis (E, I and A), polyarticular juvenile idiopathic arthritis (E), psoriatic arthritis (E, I, A, C, and G), rheumatoid arthritis (E, I, A, C, and G), ulcerative colitis (I, A and G), and uveitis (A).